A Systems Model of Gene Therapy for Sickle Cell Disease
Live & Recorded On: Tuesday, November 30, 2021 | 2pm ET / 11am PT | Applied BioMath

Stem cell gene therapy is an emerging experimental therapy for Sickle cell disease (SCD) with the potential for lifelong cure but it is an expensive multi-step treatment regimen with several months to over a year before treatment stabilization. Applied BioMath developed a quantitative systems pharmacology (QSP) model to predict how varying treatment parameters such as stem cell dose and vector copy number will affect post-treatment hemoglobin and red blood cell dynamics after autologous stem cell gene therapy. This webinar is ideal for scientists and decision makers in drug R&D who want to leverage systems pharmacology for drug discovery and development. Register Now.

The Future of Pharmaceutical Glass
Live & Recorded on: Tuesday, November 30, 2021 | 11am ET / 8am PT | Corning Pharmaceutical Technologies

Traditional pharmaceutical glass containers create processing bottlenecks that limit the efficiency of fill-finish operations. Corning Pharmaceutical Technologies has responded to these limitations by developing the next generation of primary glass packaging. This webinar will introduce Corning’s coated vial technology that provides multiple benefits to pharma and CMOs. Register Now.

Empower Medtech Sales with Deal Management for Salesforce
Live & Recorded on: Tuesday, November 30, 2021 | 12pm ET / 9am PT | Model N

During this webinar, you’ll learn how you can generate up to 17% more deals that are 2x larger on average by delivering instant access to real-time customer data and insights, streamlining the contract creation process, connecting sales-facing tools with pricing and contracting systems, and bringing your front- and back-office teams together. Register Now.

Oral solid dose formulations: Integrating patient centricity into development and lifecycle strategies
Live & Recorded on: Wednesday, December 1, 2021 | 11am ET/ 8am PT | ThermoFisher Scientific

Meeting the increasing demand for patient centricity in drug design is key to your molecule’s success. Learn how to implement development and lifecycle management strategies. Register Now.

Beyond the Science – Ensuring a Successful Business Journey from Start-up to Global Leader
Live & Recorded on: Wednesday, December 1 | 11 am ET / 8am PT | Merit Solutions

As a biotech or pharma manufacturer, your business is changing rapidly and at some point, addressing business growth pains could put your science on the backburner. How do you ensure your business operations are at pace to support your business journey without disrupting the heart of your business – the science? Attend and learn how to spot the signs and leave with a framework to help you evaluate your digital solution, including collaboration, ERP, CRM and analytics functionality in one data platform that grows as your organization grows. Register now.

Advances in Precision Medicine in Lupus and Rheumatoid Arthritis
Live & Recorded on: Thursday, December 2, 2021 | 11:00am ET / 8:00am PT | Sengenics

Precision medicine aspires to revolutionize healthcare by using novel biomarkers to individualize patient treatments and ensure that patients receive the most effective drugs the first time. This methodology aims to avoid the current trial-and-error approach to patient care. In this webinar, we review recent precision medicine studies in lupus and rheumatoid arthritis and discuss new advances in biomarker research for patient stratification. Register Now.

The Next Generation of Cell and Gene Therapies - Prospects and Challenges
Live & Recorded on: Thursday, December 2, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

During this webinar, R&D experts from gene and cell therapy companies will come together to lay out the opportunities in the field and offer advice for overcoming the inevitable hurdles that will arise. Topics include how to establish an early dialogue with the FDA, manufacturing advances that can help make cell and gene therapy scalable, and more. Register now.

Protocol Diagnostic 101: How to assess your protocol for implementation risks
Live & Recorded on: Thursday, December 2, 2021 | 11am ET / 8am PT | Pro-ficiency

Participants will join Beth in a critique (“analysis”) of some poorly written protocols (“Protocol Bloopers”) while learning what potential rewrites could look like. We will discuss the effectiveness of proactive approaches and the available tools to mitigate or prevent the compounding effects of having an ugly protocol. Register Now.

Confidently assess potential unintended binding and activity of biotherapeutics
Live & Recorded on: Monday, December 6, 2021 | 11am ET/ 8AM PT | Lonza Biologics and Integral Molecular

In this webinar, we explore the challenges of comprehensively assessing the specificity profile when moving a candidate to first-in-human (FIH) studies, through the application of membrane proteome arrays and cell-based immunotoxicity assays. Case studies will highlight how these in vitro assessments add significant value by predicting risk early and how potential clinical safety issues could have been averted by such a comprehensive approach. Register Now.

Can digital solutions at the interface of life sciences and healthcare improve health outcomes and reduce costs?
Live & Recorded on: Monday, December 6, 2021 | 11am ET / 8am PT | Innovaccer

Come join our webinar to learn about regulatory and market imperatives driving digital transformations at the intersection of medtech, providers and patients, learn about the key challenges facing the space and expert panels’ views on how to overcome these, and see some examples of success in building digital ecosystems that connect devices, patients, care teams, providers and payers to enable the 4Ps of medicine. Register Now.

Proactively Mitigating Risks to Vial System Integrity
Live & Recorded on: Wednesday, December 8, 2021 | 11 am ET / 8am PT | West Pharmaceutical Services

This webinar will focus on the regulatory expectations for container closure integrity (CCI), historic market challenges with sterile vial systems, and a new approach to container closure selection that utilizes component dimensional variability and big data. Register Now.

Next Supply Chain Challenge: Syringes
Live & Recorded on: Wednesday, December 8 | 11am ET / 2pm PT | Apiject

What’s behind the growing global shortage of syringes for COVID and other vaccinations? How is the industry meeting the demand? Hear from experts in pharma and global health discuss potential solutions. Register now.

Enabling “Direct to Consumer” Clinical Trials with Innovative Digital Platforms: A Case Study – Hearts of Athletes and COVID-19
Live & Recorded on: Thursday, December 9, 2021 | 11am ET / 8am PT | Amazon Web Services

In this webinar, learn how the Duke Heart Center launched a fully digital, decentralized clinical study leveraging Deloitte’s ConvergeHEALTH MyPath for Clinical platform powered by AWS to study the impact of COVID-19 on athletes’ heart health. Discover how this study could give us insights into the impact of COVID on elite athletes, as well as the role that cloud based digital platforms can play to accelerate recruitment and improve retention and event ascertainment to augment the in-person visits that would have been required in the past. Register now.

Latest Data in Breast Cancer Response Monitoring and Relapse Prediction
Live & Recorded on: Tuesday, December 14, 2021 | 11am ET / 8am PT | Natera

In this webinar, join us for a discussion of data showcasing the validity and utility of using circulating tumor DNA (ctDNA) across neoadjuvant, post-surgical / adjuvant, and metastatic settings, including how ctDNA clearance could supplement pCR to better predict patient outcomes during and after neoadjuvant therapy, how serial monitoring of ctDNA allows for early identification of patients at risk of progression in the post-surgical setting, and more. Register Now.


How to thrive as a new public biotech
Live & Recorded on: Thursday, November 18, 2021 | 1pm ET / 10am PT | RSM

In this webinar we help Controllers, VPs of Finance and other finance team members grapple with these questions. We will cover what it costs to bring your first drug to market, how your peers raise that required capital, when to start building your processes and people to meet the requirements for accessing public markets, and more. Register Now.

Preparing for Phase 1: Strategies for success in advancing your drug to first-in-human trials
Wednesday, November 17, 2021 | 11am ET / 8am PT | Catalent

Companies can encounter a number of pitfalls on the path to moving a drug from preclinical to clinical trials. Understanding these hurdles—and properly preparing for them—can prevent a drug development program from stalling or, worse, stopping altogether. During this webinar, biopharma R&D professionals will review strategies for moving successfully and efficiently from preclinical studies to first-in-human trials. They will call upon their own experiences to provide advice that will help others in the industry navigate this crucial transition. Register Now.

The cell therapy divide - How to navigate the challenges of taking clinical-level manufacturing capacity up to commercial scale
Live & Recorded on: Tuesday, November 16, 2021 | 11am ET / 8am PT | Catalent

When your manufacturing process depends on healthcare professionals working with the patients to get the front-end and back-end of the processes exactly right, those professionals need to understand your process unequivocally. That may mean having a team of trainers to make that happen. We’ll discuss the challenges posed by this new wave of therapies and how the pioneers in the field are tackling them. Register Now.

Weekly Triggers Fuel Omni Channel Marketing Impact in Healthcare
Live & Recorded on: Tuesday, November 16, 2021 | 11am ET / 8am PT | TI Health

Reports have shown that up to 69% of physicians want digital patient education and are up to 5X more responsive to messaging if personalized. The future of pharma is personalized omni-channel engagement, and that future is now. Join us to learn more about how we’re combining personalization with non-personal promotion to deliver 160:1 ROI for leading pharmaceutical brands. Register Now.

Accelerating clinical adoption and best practices of AI
Live & Recorded on: Thursday, November 11, 2021 | 11am ET / 8am PT | IQVIA

AI-driven automation that delivers predictive insights and drives next-best action recommendations is of critical value to life sciences. Join us to discuss AI principles and see data science in action for life sciences use cases. Register now.

State of the Art Research Methods for Value-Based Pricing
Live & Recorded on: Wednesday, November 10, 2021 | 12pm ET / 9am PT | GLG

In the healthcare industry, innovation is essential. With so many medical products developed and launched daily, pharmaceutical, healthcare services, biotechnology, medical device, diagnostic, and life science companies should clearly understand if products fit the needs of the market. To answer this, you must identify what your customers perceive as valuable. Register now.

2021 Research - The Impact of New Clinical Trial Approaches Adopted During Pandemic
Live & Recorded on: Tuesday, November 9, 2021 | 11am ET / 8am PT | Oracle

The research forecasts the continuation, as well as discontinuation, of certain approaches such as EHR, eSource, ePro, and patient apps – and the impact of these approaches on clinical trial data, quality , and speed.  It will also shed light on the industry’s level of confidence in the data generated from these new clinical trial approaches and other expectations as we step forward into the post-pandemic world. Register Now.

It’s time to expect more from your patient services hub
Live & Recorded on: Tuesday, November 9, 2021 | 1pm ET / 10am PT | Cardinal Health

Whether you’re designing a hub services program to match the unique needs of your emerging specialty product or considering a more tailored approach to your current hub strategy, this webinar will take a look at the essential interconnectivity between data and digital services. In this webinar, we will share answers to these questions and explore how technology, data, and analytics can be leveraged to create your hub success story. Register Now.

MedTech in the Post-COVID World: Where Do We Go From Here?
Trinity Life Sciences

The pandemic accelerated the reliance on data and digital health technology within the MedTech industry. Trinity shares the impact of COVID on different MedTech lines of business. We explore what best practice companies/brands are doing to address the new normal. Access the on-demand webinar.

Six Critical Factors for a Successful Commercial Launch Strategy
Live & Recorded on: Thursday, November 4, 2021 | 11am ET / 8am PT | Medidata Acorn AI

At the core of designing and executing a successful commercial launch strategy is having the right data and insights to effectively plan, execute, and adapt quickly to the market. Medidata Acorn AI Commercial Data Solutions has supported 40% of the first-time drug launches in the US so far in 2021. This webinar will address the six critical factors to consider for a successful commercial launch strategy. Register Now.

Improving the Patient Experience in Cancer
Live & Recorded on: Thursday, November 4, 2021 | 2pm ET / 11am PT | Carevive

As the healthcare industry becomes more saturated with big data, the search continues for data that can inform decisions that positively impact the experience and outcomes of patients with cancer. This webinar will illustrate how life science stakeholders can use this data to answer important questions about the experience of real world patients with cancer. Register now.

Investigating Pediatric Biomarker Reference Intervals Using New Technologies
Live & Recorded on: Wednesday, November 3, 2021 | 11am ET / 8am PT | Bio-Techne

There is minimal available data on cytokine expression in healthy children. Learn how a Canadian research team established a robust pediatric reference interval database aimed at improving the diagnosis and monitoring of children with medical concerns. And dive into the scientific method and advanced technology that is allowing them to expand the initiative. This discussion is perfect for researchers interested in immune response profiling, cytokine release syndrome and biomarker discovery. Register Now.

Inspired Exchanges: Navigating Health Communications’ Digital Transformation
Live & Recorded on: Wednesday, November 3, 2021 | 11:30am ET / 8:30am PT | GCI Health

In this 90-minute series of panel discussions, hosted by GCI Health in partnership with Fierce Pharma, experts, academics, and innovators across healthcare will share how, as communicators, we can leverage mobile tools and emerging platforms to deliver credible health information to new audiences, bridge the gaps that exist between emerging digital innovation and hard-to-reach patient communities, and engage patients through emotional marketing and communications to drive further adoption of emerging technologies and care delivery. Register Now.

Nature Laughs at the Difficulties of Integration - An expert panel documents proven methods for solving ELN integration challenges
Live & Recorded on: Wednesday, November 3, 2021 | 11am ET / 8am PT | PerkinElmer

Pierre-Simon LaPlace, a famed French scientist, stated “nature laughs at the difficulties of integration.” We have assembled a panel of integration experts to share their tips for overcoming those difficulties. Our experts discuss these challenges, and the solutions proven to resolve them. Register Now.

Clinical Adjudication Survey Results Revealed
Live & Recorded On: Tuesday, November 2, 2021 | 1pm ET / 10am PT | Clario

In a recent survey, 89% of clinical adjudication users agreed clinical adjudication provides value to clinical trials. Why? Because using unbiased experts to evaluate a drug or device against predetermined criteria helps determine patient safety and clinical efficacy. Join two experts for a discussion of these and other survey results to understand how they could impact your studies. Register Now.

Taking the “Clinic” Out of Clinical Trials - Bridging research and care with digital tools
Live & Recorded on: Tuesday, November 2, 2021 | 12pm ET / 9am PT | Huma

Clinical trials are a critical, but challenging, necessity in providing healthcare to patients. They are often expensive, difficult for patients to access, and limited in their cohort diversity. Additionally, there is often a gap in the continuation of care as patients transition from trials back to a standard healthcare setting. This webinar will bring together five industry leaders to provide their perspectives on how digital tools will ease some of the pain points in clinical trials and lead to the improvement in patient care. Register Now.

The Faster Path From Pre-Filled Syringe to Auto-Injector
Catalent Biologics

When transitioning from a traditional pre-filled syringe to an auto-injector, it’s important your manufacturing and device partners work together to help get your product to market, faster.  Watch this webinar where Ypsomed and Catalent Biologics discuss integrated approaches to do just that. Access the on-demand webinar.

Using Next Best to Elevate your Omnichannel Marketing Strategy

By leveraging the right mix of machine learning, rules-based suggestions, and marketing automation tools, pharma marketers can build a more sophisticated toolbox to support their omnichannel marketing plans. Watch the on-demand webinar to learn more.

Launching a First Product in Europe - The Supply Chain Perspective
Live & Recorded On: Wednesday, October 27, 2021 | 11am ET / 8am PT | AIM

An efficient supply chain is critical to any first launch in Europe. This webinar will identify and address the critical aspects that companies must consider when creating a distribution and financial infrastructure in Europe.  Our expert panel will share their experiences, as well as discuss the key benchmarks and pitfalls on the journey to building the optimal supply chain infrastructure. Register Now.

An RNA-Based Assay Designed to Predict Patient Response to Angiogenic and Immune Targeted Therapies
Live & Recorded on: Wednesday, October 27, 2021 | 11am ET / 8am PT | Qiagen

In this webinar, with Mark Uhlik from OncXerna Therapeutics – discover how the Xerna TME Panel was developed to understand the dominant biology of the tumor microenvironment and align to particular therapeutic modalities. Register Now.

Implementing Decentralized or Hybrid Trials – New roles, processes and technologies transforming clinical development
Live & Recorded on: Tuesday, October 26, 2021 | 11am ET / 8am PT | IQVIA

Understand what it takes to implement a Decentralized Trial (DCT), including new roles, processes, and new technologies. Register now to hear lessons learnt and Case Studies in delivering global DCTs. Register Now.

The Patient Journey at the Center of Digital Disruption
Live & Recorded on: Thursday, October 21, 2021 | 1pm ET / 10am PT | Guidehouse

This webinar will be looking at the holistic digital patient journey emphasizing crucial points of intersection of patients, payers and providers. The discussion will focus on how digital solutions can be optimally effective by not just providing a narrow service, but by engaging and empowering patients throughout their entire healthcare journey. Register Now.

The Next-Generation of Antibody Libraries for Therapeutic Discovery
Live & Recorded on: Wednesday, October 20, 2021 | 2pm ET / 11am PT | Twist Bioscience

In this webinar, we discuss the latest in library synthesis technology, and its use to build innovative libraries that harness structural and developability features to cover a wide range of antibody drug targets. We show how these libraries enable the discovery of high-affinity drug-like antibodies, often without the need for affinity maturation. Register Now.

New ctDNA data in response monitoring
Live & Recorded on: Thursday, October 14, 2021 | 11am ET / 8am PT | Natera

Learn about the latest advances in leveraging bespoke ctDNA testing in clinical trials. Find out how Signatera has been applied in early stage and late stage disease. Dive into New published and presented data across multiple tumor types. Discover improvements to clinical trial design with Signatera including: identifying early relapsers, enriching for patients potentially most likely to respond to therapy, accelerating time to trial readout, predicting clinical outcomes as early as 6 weeks into treatment. Register Now.

Accelerating Clinical Development with Expanded Access
Live & Recorded On: Wednesday, October 13, 2021 | 1pm ET / 10am PT | Rho

Join this webinar to learn how Expanded Access can advance and accelerate development of products to treat serious conditions, including strategic considerations and the regulatory utility of data from Expanded Access programs. Register now.

The power of a digital thread in pharma
Live & Recorded On: Wednesday, October 13, 2021 | 11am ET / 8am PT | Accenture AWS Business Group

AWS and Accenture share how they help transform pharma manufacturing, supply chain and quality control processes to deliver more personalized products faster and improve the patient experience. Register Now.

Highly Potent API Drug Product Development and Manufacturing Using Micronization Technology
Live & Recorded On: Tuesday, October 12, 2021 | 11am ET / 8am PT | Catalent

Development of HPAPIs presents unique challenges for product containment and requires special consideration in equipment selection, operating procedures, and safety processes. This webinar will discuss how to classify HPAPIs in early development and share recommendations for safe product handling, from clinical manufacturing to commercialization. The speakers will also share the key advantages of using micronization technology for the development and manufacturing of HPAPIs. Register Now.

Delivering Streamlined Processes and Customer-Centricity in the HLS Industry
Thursday, October 7, 2021 | 2pm BST / 9am ET | FinancialForce

Join this webinar to explore how running a customer-centric organization leads to organisational agility, process efficiency, and ultimately faster speed of innovation. Register now.

Building a robust FIH biologics regulatory CMC package
Live & Recorded On: Thursday, October 7, 2021 | 2pm ET / 11am PT | Thermo Fisher Scientific

Join us to learn how to develop a robust first-in-human (FIH) regulatory CMC package for recombinant biological molecules by integrating the following activities into your project plan: progressively developing knowledge of the molecule’s critical quality attributes to justify the manufacturing and control strategy, planning for continuing development, and identifying opportunities to enhance with scientific advice. Register Now.

The Future of Genomics in Healthcare and Medicine
Live & Recorded On: Wednesday, October 6, 2021 | 1pm ET / 10am PT | SurveyHealthcareGlobus

In this webinar, you will learn physician’s current and expected futures use of genomic sequencing, the impact of genome sequencing on individual healthcare, views on how genome sequencing will change the practice of medicine, perspectives on physicians’ concerns about genome sequencing for their patients, and how genome sequencing is changing cancer treatment plans. Register Now.

What is the Future Landscape of Cell and Gene Therapies?
Wednesday, October 6, 2021 | 11am ET / 8am PT | Veristat

Favorable regulatory outcomes and a high demand for novel and on-demand cell and gene therapies has poised viral vector manufacturing for a significant jump. With new efficiencies on the horizon, what does this mean for the future of these therapies and their potential to treat a wider patient population? Register now.

Finding the right patients for clinical trials
Live & Recorded On: Tuesday, October 5, 2021 | 11am ET / 8am PT | uMed

We’ll explore the landscape of technologies and services that match patients to clinical trials, providing feedback from CRO executives who have experience with them. Topics include how innovative technology is being harnessed to extract information from electronic medical records in order to identify the most appropriate patients for clinical trials, best practices for using social media to match patients to clinical trials, and more. Register Now.

Getting your global, small molecule CMC regulatory strategy right from the start
Thursday, September 30, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

Navigating each phase of your small molecule’s journey with the right CMC strategy is a critical component to enable success. Register Now.

Explore the Depths of Radiomic Data in Clinical Trials
Live & Recorded On: Monday, September 27, 2021 | 2pm ET / 11am PT | HealthMyne

Join this interactive panel to explore the depths of radiomic data in clinical trials. Learn real world applications and practical strategies for radiomic use in clinical trials, personalized drug development and therapy response. Register Now.

Bespoke & flexible cell line development programs from gene to clinic
Thursday, September 23, 2021 | 11am ET / 8am PT | Lonza

To learn how you can chart an optimal path from gene to the clinic by tailoring your cell line development program to match your molecule type, timelines, yield requirements and risk priorities, register for our webinar now.

Eliminating Problems in Drug Development - Understanding the Role of Drug Metabolism
Thursday, September 23, 2021 | 1pm ET / 10am PT | SEKISUI XenoTech

This talk will discuss processes for the metabolism of a drug, referred to as ADME, and the safety testing to provide requisite information to move a drug through IND and into clinical trials. Prior to marketing a new drug and actually prior to administering a candidate drug to humans in clinical trials, it is important to ensure that drug will not only be effective in the therapeutic manner prescribed, but also be safe and not bring any undo harm to patients. If you are involved in the development of potential new therapeutics, this discussion will help you gain necessary knowledge to inform your drug development decisions. Register Now.

De-risk injectable drug development using elastomer barriers and films
Wednesday, September 22, 2021 | 11am ET / 8am PT | West Pharmaceutical Services

Did you know that not all elastomeric component surface barriers are created equal? Gain insight from West experts, Fran DeGrazio and Peggy Frandolig, in a free webinar on September 22. Register Now.

Becoming the early bird - Establishing a dialogue with the FDA around accelerating preclinical research
Live & Recorded on: Tuesday, September 21, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

This webinar will bring together experts in preclinical trial design, R&D efficiency and regulatory affairs to offer advice on how companies can best engage the FDA early in the research process. Topics include strategies for determining the best timeline for approaching the FDA with a new drug candidate, a review of new technologies designed to speed up preclinical testing, and ensuring the proper balance between streamlining preclinical research and gathering enough data to satisfy regulators. Register Now.

Building a data strategy that goes beyond the data lake
Recorded on Tuesday, September 21, 2021 | Innovaccer & AWS

A data lake is a great first step to transforming real world data into real world evidence that can be trusted to make critical decisions that drive forward the life changing therapies that you bring to patients today and tomorrow. During this webinar, hear from ex-CTO of Kaiser Permanente, ex- Data strategy leader of Merck, AWS Cloud Life Science leader and the LS product leader from Innovaccer on why we all need to think ‘beyond the data lake’. Save Your Spot.

Proven Quality - Preventing quality issues during drug development
Recorded on Monday, September 20, 2021 | Catalent

Many drug developers naturally turn to contract manufacturers, but even with the best, they need to stay deeply involved, and aware of what is happening with their CDMO. A manufacturing plant that runs into FDA concerns, even for something unrelated to your efforts, can still delay years of work and the rewards of a drug approval. We’ll look at the diverse set of tactics companies can use to forestall manufacturing disappointments, from recruitment to partnerships to regulatory communication and more. Register Now.

Rethink your commercialization strategy
Thursday, September 16, 2021 | 11am ET / 8am PT | AmerisourceBergen

Is it time to rethink your approach to commercialization? Learn how the right partner and mix of solutions can put you on the path to delivering disruption innovation. Register Now.

Next Best for Account Management - It’s not just for Omnichannel anymore
Recorded on Thursday, September 16 | IQVIA

In this webinar, we will look into how Next Best programs can be leveraged to support account-based engagement models, and consider the right opportunities to leapfrog industry leaders by enhancing proven models with technology-based coordination and insights-led decision processes. Register now.

Removing Antibody Drug Discovery's DNA Bottleneck
Recorded on Tuesday, September 14, 2021 | Twist Bioscience

G protein-coupled receptors (GPCRs) are one of the most promising drug targets due to their pathophysiological role in the human body. However, at the same time, GPCRs have proven to be one of the most challenging targets for antibody drug development. This webinar will describe the use of next-generation DNA synthesis tools to overcome the DNA bottleneck in antibody-based GPCR drug discovery, the discovery and creation of both antagonistic and agonistic GLP-1R antibodies by panning this GPCR-focused phage display library on a GLP-1R overexpressing Chinese hamster ovary cell line, and more. Register Now.

Avoiding pitfalls in sterile manufacturing
Recorded on Thursday, September 9, 2021 | Grand River Aseptic Manufacturing

While the rapid development of COVID-19 vaccines helped to wind down the pandemic, it also brought to light the many challenges involved in ramping up the production of injectables that must be made in sterile, aseptic environments. Several companies struggled to compress what’s normally a year-long process of getting up to speed into a matter of months. Such pitfalls can be avoided, however, by improving planning processes and adopting new technologies to streamline manufacturing. Register Now.

Effective Scale-Up and Technology Transfer Strategies for Spray Dried Pharmaceutical Products
Wednesday, September 8, 2021 | 11am ET / 8am PT | Catalent

This webinar features a Catalent expert presenting a roadmap for formulation and process development that can aid in seamless scale-up. Another expert from EuroAPI will provide an overview of typical tech transfer and scale-up processes, highlighting how thermodynamic modelling, engineering modifications, API conservation and cleaning techniques in large scale settings can help optimize overall processes in terms of yield and run times. Register now.

MDR conform development of sterile Medical Devices
Recorded on Wednesday, September 1, 2021 | Fresenius Kabi

The Webinar will cover challenges of MDR for sterile medical device manufacturing companies, phases of Design Control for the development process of sterile disposable medical devices, advantages of a one-stop-shop during development and production in MDR environment, and contract Manufacturing partnership. By attending the webinar, you will get insight on MDR requirements and their impact on the development of medical devices, relevance of adequate documentation during MDR conform development of sterile medical devices, and advantages of Contract Manufacturing as strategic partnership to fulfill MDR requirements--especially for pharmaceuticals companies. Register Now.

Preparing for an evolving regulatory landscape to successfully commercialize cell and gene therapies
Tuesday, August 31, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

Monica Commerford, Ph.D., Head of Regulatory Affairs at Thermo Fisher Scientific, discusses the strategies available to meet critical regulatory requirements to accelerate early to late state CMC product development. Register Now.

Accelerate late-phase drug development with continuous manufacturing
Wednesday, August 25, 2021 | 11am ET / 8am PT | Thermo Fisher Scientific

Continuous manufacturing enables late-phase development by ensuring quality assurance and reducing API usage. Attend this webinar to learn how to create a strategy that reduces total cost of ownership. Register Now.

How lessons learned from the COVID pandemic will improve vaccine development in the future
Recorded on Wednesday, August 11, 2021 | Catalent

During the COVID-19 pandemic, several pharma companies moved so fast to develop vaccines that the amount of time between the sequencing of the virus to the introduction of the first three vaccines was less than a year. This Fierce webinar will include input from vaccine R&D professionals, including experts in clinical trial design, regulatory affairs and manufacturing. They will draw upon their own experiences in vaccine development to offer tips for incorporating elements of the successful COVID-19 vaccine rollout into future vaccine programs. Register Now.

COVID-19 Virus Sequencing for Drug Development
Recorded on Wednesday, July 28, 2021 | Labcorp Drug Development

In this webinar, we will establish the medical backdrop for COVID-19 virus sequencing in drug development, connect insights from population surveillance to potential solutions for drug developers, describe the biological relevance of sequencing in drug development, and outline approaches to COVID-19 virus sequencing, including the application of both targeted and whole genome sequencing to drug development. Register now!